Selective Wealth Management’s VanEck Biotech ETF BBH Stock Holding History

Selective Wealth Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-450	Closed	-$85K	–	724
2021 Q4	$85K	Hold	450	–	–	0.03%	212
2021 Q3	$91K	Buy	450 +300	+200%	+$63K	0.05%	195
2021 Q2	$30K	Buy	+150	New	+$27.9K	0.02%	239

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

Selective Wealth Management's BBH Position: Q1 2022 in Review

Selective Wealth Management sold out of VanEck Biotech ETF (BBH) in Q1 2022, closing a stake of 450 shares — an estimated $85K sold.

Selective Wealth Management first reported a position in BBH in Q2 2021 and held it in 3 quarters. The position peaked at $91K in Q3 2021. 115 funds tracked by Wall St. Rank hold BBH as of Q1 2022.

Selective Wealth Management reported no remaining VanEck Biotech ETF position as of Q1 2022 after selling out during the quarter.
Selective Wealth Management sold 450 VanEck Biotech ETF shares in Q1 2022, an estimated $85K.
Selective Wealth Management first reported a position in VanEck Biotech ETF in Q2 2021 and held it in 3 quarters.
Selective Wealth Management's VanEck Biotech ETF position peaked at $91K in Q3 2021.
115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2022.

Based on Selective Wealth Management's 13F filing for Q1 2022, filed 20 Apr 2022.